Tag: Astrazeneca
AstraZeneca: green light from the FDA in rare neuropathy
(CercleFinance.com) – The American drug authority, the Food and Drug Administration (FDA), has approved a drug developed by AstraZeneca and its partner Ionis against a rare neuropathic disease likely to…
AstraZeneca and Sanofi to supply 230,000 additional RSV vaccines for infants to the US market – 12/14/2023 at 10:38 p.m.
(Adds details from Sanofi in paragraphs 2, 9 and 10) by Trevor Hunnicutt and Michael Erman Makers of a respiratory syncytial virus (RSV) vaccine for infants, whose supply is limited,…
AstraZeneca buys respiratory vaccine developer Icosavax for $1.1 billion – 12/12/2023 at 11:08 a.m.
(Added quote from interview in paragraph 5, actions of Icosavax in paragraph 3, history and context throughout) by Yadarisa Shabong AstraZeneca AZN.L said on Tuesday it had agreed to buy…
AstraZeneca: Positive results from danicopan trial
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
AstraZeneca: positive results from danicopan trial
(CercleFinance.com) – AstraZeneca announces positive results from a pivotal phase III trial showing that danicopan, in addition to standard C5 inhibitor treatment, Ultomiris (ravulizumab) or Soliris (eculizumab) continued to demonstrate…
AstraZeneca: Collaboration with Absci in AI
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
AstraZeneca: termination of two phase III trials on Lokelma
(CercleFinance.com) – AstraZeneca announced the termination of the STABILIZE-CKD and DIALIZE-Outcomes phase III trials for Lokelma (sodium zirconium cyclosilicate). This decision was made due to a significant increase in registration…
Cellectis: Signature of the definitive agreement with AstraZeneca
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
AstraZeneca prioritizes US for its RSV drug due to rising cases – 11/10/2023 at 8:18 p.m.
by Patrick Wingrove and Maggie Fick AstraZeneca AZN.L said on Friday it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was…
AstraZeneca: exclusive licensing agreement with Eccogene
(CercleFinance.com) – AstraZeneca announces that it has entered into an exclusive licensing agreement with Eccogene for ‘ECC5004’, an experimental daily oral treatment aimed at combating obesity, type 2 diabetes and…
AstraZeneca: encouraging results in liver cancer
(CercleFinance.com) – AstraZeneca announces that the results of a phase III trial showed that Imfinzi (durvalumab), combined with transarterial chemoembolization (TACE, a therapy for the treatment of liver cancer) and…
AstraZeneca: positive results around Lokelma
(CercleFinance.com) – AstraZeneca announces that the results of a multi-country observational study presented today at the American Society of Nephrology (ASN) show that the treatment of hyperkalemia (HK) with the…